Quality of Life Change Archives

01 September, 2022

Testing the in vivo efficacy of base and prime editing in primary fibroblasts and in a 3D skin model of dystrophic epidermolysis bullosa...

01 April, 2021

Testing the efficacy of genomic base editing in dystrophic epidermolysis bullosa primary fibroblasts...

01 January, 2021

Development of a topical gene-editing treatment to restore Collagen VII...

01 December, 2020

Combined respiratory epithelial cell and gene therapy for amelioration of respiratory symptoms in children with Junctional Epidermolysis Bullosa...

01 October, 2020

Pre-clinical and clinical trial for using gene-edited skin in Recessive Dystrophic Epidermolysis Bullosa...

01 September, 2020

A nanoneedle bandage for topical intracellular COL7A1 gene therapy to accelerate wound healing in RDEB...

01 September, 2018

Phase I/II ex vivo gene therapy clinical trial for RDEB using genetically corrected autologous skin equivalent grafts...

01 December, 2016

Next generation genome editing for Recessive Dystrophic Epidermolysis Bullosa...

01 April, 2016

Stem cell regeneration of the ocular surface in Recessive Dystrophic Epidermolysis Bullosa...

01 July, 2015

Phase I study of lentiviral-mediated COL7A1 gene-modified autologous fibroblasts in adults with Recessive Dystrophic Epidermolysis Bullosa...

Archive